Zacks Research Predicts Neogen’s Q3 Earnings (NASDAQ:NEOG)

Neogen Co. (NASDAQ:NEOG) – Research analysts at Zacks Research decreased their Q3 2025 earnings per share (EPS) estimates for Neogen in a research report issued on Wednesday, February 12th. Zacks Research analyst R. Department now anticipates that the company will earn $0.11 per share for the quarter, down from their prior forecast of $0.12. The consensus estimate for Neogen’s current full-year earnings is $0.38 per share.

Several other research analysts have also issued reports on NEOG. Piper Sandler reaffirmed a “neutral” rating and set a $13.00 target price (down from $16.50) on shares of Neogen in a research report on Tuesday, January 21st. Guggenheim began coverage on Neogen in a research report on Thursday, December 19th. They set a “buy” rating and a $15.00 target price for the company.

Neogen Stock Up 5.7 %

Shares of NASDAQ:NEOG opened at $10.39 on Monday. The firm has a market cap of $2.25 billion, a P/E ratio of -4.74 and a beta of 1.23. The company has a quick ratio of 2.46, a current ratio of 3.77 and a debt-to-equity ratio of 0.33. Neogen has a 12-month low of $9.70 and a 12-month high of $18.58. The business has a fifty day simple moving average of $11.66 and a 200 day simple moving average of $14.08.

Neogen (NASDAQ:NEOG) last released its quarterly earnings data on Friday, January 10th. The company reported $0.11 earnings per share for the quarter, beating the consensus estimate of ($0.01) by $0.12. Neogen had a positive return on equity of 2.89% and a negative net margin of 52.12%. The company had revenue of $231.30 million for the quarter, compared to the consensus estimate of $227.16 million. During the same quarter last year, the business posted $0.11 EPS. Neogen’s revenue for the quarter was up .7% on a year-over-year basis.

Insider Transactions at Neogen

In other news, CEO John Edward Adent bought 23,035 shares of the firm’s stock in a transaction that occurred on Thursday, January 16th. The stock was acquired at an average cost of $11.03 per share, with a total value of $254,076.05. Following the transaction, the chief executive officer now directly owns 269,164 shares of the company’s stock, valued at approximately $2,968,878.92. This represents a 9.36 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO David H. Naemura bought 14,800 shares of the firm’s stock in a transaction that occurred on Thursday, January 16th. The stock was purchased at an average cost of $11.11 per share, with a total value of $164,428.00. Following the completion of the transaction, the chief financial officer now directly owns 61,434 shares in the company, valued at $682,531.74. This represents a 31.74 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Corporate insiders own 1.13% of the company’s stock.

Hedge Funds Weigh In On Neogen

A number of hedge funds have recently added to or reduced their stakes in the stock. Stephens Inc. AR boosted its stake in Neogen by 2.6% during the 3rd quarter. Stephens Inc. AR now owns 35,930 shares of the company’s stock valued at $604,000 after purchasing an additional 909 shares during the last quarter. Connable Office Inc. boosted its stake in Neogen by 5.6% during the 4th quarter. Connable Office Inc. now owns 18,793 shares of the company’s stock valued at $228,000 after purchasing an additional 1,000 shares during the last quarter. Allspring Global Investments Holdings LLC boosted its stake in Neogen by 142.6% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 1,982 shares of the company’s stock valued at $33,000 after purchasing an additional 1,165 shares during the last quarter. Covestor Ltd boosted its stake in Neogen by 41.4% during the 4th quarter. Covestor Ltd now owns 4,103 shares of the company’s stock valued at $50,000 after purchasing an additional 1,202 shares during the last quarter. Finally, Inspire Advisors LLC boosted its stake in Neogen by 10.1% during the 4th quarter. Inspire Advisors LLC now owns 14,226 shares of the company’s stock valued at $173,000 after purchasing an additional 1,304 shares during the last quarter. Institutional investors and hedge funds own 96.73% of the company’s stock.

Neogen Company Profile

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.